While the 3 researchers Daniel Drucker, Joel Haebner and Jens Juul Holst who discovered GLP-1 have been widely and appropriately recognized for this groundbreaking work, it was developed exclusively for the treatment of diabetes
The rise of GLP-1 medications could potentially represent more than just another market headwind, fundamentally reshaping consumer behavior and, by extension, the CPG landscape
Formally placing the substances on FDAs list of drugs that are safe for compounding would require new regulations, which can take months or years to draft
If you have fatty liver, expect your enzymes to normalize within one month
Step 3: Insert the Needle Pick up new syringe and attach to it a needle
doi: 10.3389/fgstr.2026.1790420 Received 18 January 2026 Revised 18 April 2026 Accepted 27 April 2026 Published 18 May 2026 Volume 5 - 2026 Edited by Glen A